2009
2009
Abedin SA, Thorne J, Battaglia S, Maguire O, Hornung L, Doherty AP, Mills IG, Campbell MJ. Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells Carcinogenesis 2009; 30:449-456.
Beerman TA, Gawron L, Shin S, Shen B, McHugh M. C-1027, a radiomimetic enediyne anti-cancer drug, preferrentially targets hypoxic cells. Cancer Res 2009; 69:593-598.
Bhattacharya A, Toth K, Sen A, Seshadri M, Cao C, Durrani F, Faber E, Repasky E, Rustum Y. Inhibition of colon cancer growth by methylselenocysteine - induced angiogenic chemomodulation is influenced by histological characteristics of the tumor. Clin Colorectal Cancer 2009; 8:155-162.
Bistulfi G, Diegelman P, Foster BA, Kramer DL, Porter CW, Smiraglia DJ. Polyamine biosynthesis impacts cellular folate requirements necessary to maintain S-adenosylmethionine and nucleotide pools. FASEB J, 2009 [E-pub ahead of print May 5].
Campbell MJ. Myeloid differentiation continues to reveal the complexity of nuclear receptor signaling. Cell Cycle 2009; 8:675.
Chanan-Khan AA, Niesvizky R, Hohl RJ, Zimmerman TM, Christiansen NP, Schiller GJ, Callander N, Lister J, Oken M, Jagannath S. Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma. Leuk Lymphoma 2009; 50:559-565.
Chen SC, Henry DO, Hicks DG, Reczek PR, Wong MKK. Intravesical administration of Plasminogen activator inhibitor type-1 inhibits in vivo bladder tumor invasion and progression. J Urol 2009:181:336-342.
Choi J-Y, James SR, Link PA, McCann SE, Hong C-C, Davis W, Nesline MK, Ambrosone CB, Karpf AR. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis, July 7, 2009 [E-pub ahead of print]
Chung I, Han G, Seshadri M, Gillard B, Yu W-D, Foster BA, Trump DL, Johnson CS. Role of VDR in Anti- proliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis in vivo. Cancer Research 2009; 69:967-975.
den Hollander A, McGee TL, Ziviello C, Banfi S, Dryja TP, Gonzalez-Fernandez F, Ghosh D, Berson E. A homozygous missense mutation in the IRBP gene (RBP3) associated with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci 2009; 50:1864-1872.
Fakih MG, Pendyala L,Fetterly G, Toth K, Zwiebel JA, Espinoza-Delgado I, Litwin A, Rustum YM, Ross ME, Holleran JL, Egorin MJ. A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer. Clin Cancer Res. 2009; 15:3189-3195.
Fakih MG, Rustum YM. Does celecoxib have a role in the treatment of patients with colorectal cancer? Clinical Colorectal Cancer 2009; 8:11-14.
Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J, Sunga AY. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Disease 2009; 24:219-224.
Ghosh D, Griswold J, Erman M, Pangborn W. Structural Basis for Androgen Specificity and Oestrogen Synthesis in Human Aromatase. Nature 2009; 457:219-223.
Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis C, Zaehres H, Daley GQ, Tang DG. Functional evidence that the self-renewal gene NANOG regulates human tumor development (p N/A). Stem Cells 2009; 27:993-1005.
Karpf AR, Bai S, James SR, Mohler JL, Wilson EM. Promoter DNA hypomethylation and cyclic AMP regulation of androgen receptor coregulator MAGE-11 in prostate cancer. Molecular Cancer Research 2009; 7:523-535.
Khoury T, Alrawi S, Ramnath N, Li Q, Grimm M, Black J, Tan D. Eukaryotic initiation factor-4E (eIF4E) and cyclin D1 expression associated with patient survival in lung cancer. Clinical Lung Cancer 2009; 10:58-66.
Li F. Every single cell clones from cancer cell lines growing tumors in vivo may not invalidate the cancer stem cell concept. Mol Cells 2009; 27:491-492.
Link PA, Gangisetty O, James SR, Woloszynska-Read A, Tachibana M, Shinkai Y, Karpf AR. Distinct roles for histone methyltransferases G9a and GLP in cancer germline antigen gene regulation in human cancer cells and murine ES cells. Molecular Cancer Research 2009; 7:851-862.
Liu W, Ip MM, Podgorsak MB, Das GM. Disruption of estrogen receptor alpha- p53 interaction in breast tumors: A novel mechanism underlying the anti-tumor effect of radiation therapy. Breast Cancer Research and Treatment 2009; 115:43-50.
Mathew G, Timm EA, Sotomayor P, Godoy A, Montecinos VP, Smith GJ, Huss WJ. ABCG2-Mediated DyeCycle Violet Efflux Defined Side Population in Benign and Malignant Prostate. Cell Cycle 2009; 8:1053-1061.
Mavis CK, Morey Kinney SR, Foster BA, Karpf AR. Expression level and DNA methylation status of Glutathione S-transferase genes in normal murine prostate and TRAMP tumors. The Prostate 2009; 69:1312-1324.
McGuire JJ, Bartley DM, Tomsho JW, Haile WH, Coward JK. Inhibition of human folylpolyglutamate synthetase by diastereomeric phosphinic acid mimics of the tetrahedral intermediate. Arch Biochem Biophys 2009; 488:140-145.
McGuire JJ, Haile WH. Metabolism-blocked antifolates as potential anti-rheumatoid arthritis agents: 4-Amino-4-deoxy-5,8,10-trideazapteroyl-D,L-4’-methyleneglutamic acid (CH-1504) and its analogs. Biochem Pharmacol 2009; 77:1161-1172.
McHugh MM, Beerman TA. An extraction-free method by which a single slot blot can be used to quantify intracellular DNA damage (crosslinks or strand breaks) and changes in replication or DNA damage response proteins. BioTechniques 2009; 46:126-129.
Mihich E. Twentieth Annual Pezcoller Symposium: Molecular Biology of Cancer -- 20 Years of progress punctuated by the Pezcoller Symposia. Cancer Research 2009; 69:407-410.
Morrison CD, Cheney RT, Johnson CS, Smith GJ, Mohler JL. Central Quadrant Procurement of Radical Prostatectomy Specimens. Prostate 2009; 69:770-773.
Muindi JR, Johnson CS, Trump DL, Christy R, Engler KL, Fakih MG. A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors. Cancer Chemother Pharmacol, 2009 Apr 26, [Epub ahead of print]; PMID: 19396601.
Oliver CM, Schaefer AL, Greenberg EP, Sufrin JR. Microwave synthesis and evaluation of phenacylhomoserine lactones as anticancer compounds that minimally activate quorum sensing pathways in Pseudomonas aeruginosa. J Med Chem 2009; 52:1569-1575.
Pysz MA, Leontieva OV, Bateman NW, Uronis JM, Curry KJ, Threadgill DW, Janssen K-P, Robine S, Velcich A, Augenlicht LH, Black AR, Black JD. Protein kinase C α tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1. Exp Cell Res 2009; 315:1415-1428.
Shah SK, Trump DL, Sartor O, Tan W, Wilding GE, Mohler JL. Phase II study of Dutasteride for recurrent prostate cancer during androgen deprivation therapy. J Urol 2009;181:621-626.
Sotomayor P, Godoy A, Smith GJ, Huss WJ. Oct4A is Expressed by a Subpopulation of Prostate Neuroendocrine Cells. The Prostate 2009; 69:401-410.
Sufrin JR, Finckbeiner S, Oliver CM. Marine-derived metabolites of S-adenosylmethionine as templates for new anti-infectives. Marine Drugs 2009; 7:401-434.
Thorne J, Campbell MJ, Turner BM. Transcription factors, chromatin and cancer. Intl J Biochemistry and Cell Biology 2009; 41:164-175.
Trump DL, Chadha M, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W, Johnson CS. Vitamin D Deficiency and Insufficiency among Patients with Prostate Cancer. British J Urol, 2009 Apr 4, [Epub ahead of print] PMID 19426195.
Wang X, Chinnam M, Wang J, Wang Y, Zhang X, Marcon E, Moens P, Goodrich DW. Thoc1 deficiency compromises gene expression necessary for normal testis development in the mouse. Mol Cell Biol 2009; 29:2794- 2803.
Warren MA, Shoemaker SF, Shealy DJ, Bshar W, Ip MM. TNF deficiency inhibits mammary tumorigenesis and a TNF neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice. Molecular Cancer Therapeutics, 2009 Sept 15 [EPub ahead of print].
Zahedi K, Lentsch AB, Okaya T, Barone S, Sakai N, Witte DP, Arend LJ, Ahonen L, Jell J, Janne J, Porter CW, Soleimani M. Spermidine/spermine N1-acetyltransferase ablation protects against liver and kidney ischemia-reperfusion injury in mice. Am J Physiol Gastrointest Liver Physiol 2009; 296:G899-909.


